ESMO 2024 Le PIONeeR Project présente pour la première fois les résultats de son étude clinique de phase Ib/IIa. fr.ap-hm.fr/actu/esmo-20...#ESMO24#PIONeeRProject#Oncologie#Immunothérapie#RechercheMédicale#NSCLC#CancerDuPoumon#InnovationSanté#Phase1b2a#EssaiClinique#RHU#Marseille
Retroactive study presented at a conference over the weekend suggests that mRNA vaccines might boost the efficacy of cancer immunotherapy treatments. More work would need to be done to show if this is a real effect but it's interesting. endpts.com/esmo24-in-su...
In surprise, study suggests Covid mRNA vaccines may boost cancer immunotherapy efficacy
The mRNA-based Covid vaccines used by hundreds of millions of people may provide an unexpected benefit to some cancer patients, significantly improving survival when given within a few months of immun...